Workflow
Progyny, Inc. Announces Fourth Quarter 2024 Results
PGNYProgyny(PGNY) GlobeNewswire·2025-02-27 21:01

Core Insights - Progyny, Inc. reported a quarterly revenue of 298.4million,reflectinga10.6298.4 million, reflecting a 10.6% growth compared to the previous year, marking the tenth consecutive year of revenue growth [1][8][12] - The company generated 52.2 million in quarterly operating cash flow and provided financial guidance for 2025, projecting revenue growth of 1% to 5% [1][28] - The CEO highlighted improved member engagement trends as the company enters its tenth year in the market, emphasizing the unique approach to value-based care [2][3] Financial Highlights - Fourth Quarter 2024 Results: - Revenue: 298.4million,up10.6298.4 million, up 10.6% from 269.9 million in Q4 2023 [4][8] - Gross Profit: 63.4million,an1163.4 million, an 11% increase from 56.9 million in Q4 2023 [9] - Net Income: 10.5million,or10.5 million, or 0.12 per diluted share, down from 13.5million,or13.5 million, or 0.13 per diluted share in Q4 2023 [10][11] - Adjusted EBITDA: 47.5million,a1047.5 million, a 10% increase from 43.2 million in Q4 2023 [11] - Full Year 2024 Results: - Revenue: 1,167.2million,a7.21,167.2 million, a 7.2% increase from 1,088.6 million in 2023 [12] - Gross Profit: 253.4million,up6.1253.4 million, up 6.1% from 238.8 million in 2023 [13] - Net Income: 54.3million,or54.3 million, or 0.57 per diluted share, down from 62.0million,or62.0 million, or 0.62 per diluted share in 2023 [14] - Adjusted EBITDA: 198.8million,a6.2198.8 million, a 6.2% increase from 187.1 million in 2023 [15] Cash Flow and Financial Position - Net cash provided by operating activities for 2024 was 179.1million,comparedto179.1 million, compared to 188.8 million in 2023 [17] - As of December 31, 2024, the company had total working capital of approximately 304.1millionandnodebt[18]Thecompanyrepurchased3,248,298sharesfor304.1 million and no debt [18] - The company repurchased 3,248,298 shares for 52.5 million in Q4 2024, totaling 12,382,193 shares repurchased in 2024 [22] Client and Market Metrics - The company had 473 clients as of December 31, 2024, compared to 392 clients a year earlier [23] - Fertility benefit services revenue was 187.5millioninQ42024,a9187.5 million in Q4 2024, a 9% increase from 171.3 million in Q4 2023 [19] - Pharmacy benefit services revenue was 111.0millioninQ42024,a13111.0 million in Q4 2024, a 13% increase from 98.6 million in Q4 2023 [19] Financial Outlook - For the full year 2025, revenue is projected to be between 1.175billionand1.175 billion and 1.225 billion, with net income expected to be between 45.0millionand45.0 million and 53.9 million [28] - For Q1 2025, revenue is projected to be between 300.0millionand300.0 million and 318.0 million, reflecting growth of 8% to 14% [28]